2.投资者保护能力 天健会计师事务所（特殊普通合伙）（以下简称"天健"）具有良好的投资者 保护能力，已按照相关法律法规要求计提职业风险基金和购买职业保险。截至 2024 年末，累计已计提职业风险基金和购买的职业保险累计赔偿限额合计超过 2 亿元，职业风险基金计提及职业保险购买符合财政部关于《会计师事务所职业风 险基金管理办法》等文件的相关规定。 天健近三年存在执业行为相关民事诉讼，在执业行为相关民事诉讼中存在承 担民事责任情况，具体情况如下： 广州思林杰科技股份有限公司董事会审计委员会 关于会计师事务所 2024 年度履行监督职责情况报告 根据《国有企业、上市公司选聘会计师事务所管理办法》《上海证券交易所 科创板上市公司自律监管指引第 1 号--规范运作》等规定和要求，广州思林杰科 技股份有限公司（以下简称"公司"）董事会审计委员会本着勤勉尽责的原则认真 履职。现将公司董事会审计委员会对会计师事务所 2024 年度履职评估及履行监 督职责的情况汇报如下: 一、聘请会计师事务所基本情况 （一）机构信息 1.基本信息 | 事务所名称 | | | | | | | | | | | | | | 天健会计师事务所（特殊普 ...

证券代码：688115 证券简称：思林杰 公告编号：2025-025 广州思林杰科技股份有限公司 关于召开2024年年度股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 2024年年度股东会 （二） 股东会召集人：董事会 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 5 月 19 日 14 点 30 分 召开地点：广州市番禺区石基镇亚运大道 1003 号 2 号楼公司会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 19 日 至2025 年 5 月 19 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 股东会召开日期：2025年5月19日 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 东会召开当日的交易时间 ...

证券代码：688115 证券简称：思林杰 公告编号：2025-023 广州思林杰科技股份有限公司 第二届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 广州思林杰科技股份有限公司（以下简称"公司"）第二届监事会第十四次 会议于 2025 年 4 月 24 日 16:30 在公司会议室以现场方式召开，会议通知及会议 材料于 2025 年 4 月 14 日以电子邮件方式送达全体监事。会议应参加监事 3 人， 实际参加监事 3 人，董事会秘书列席本次会议。会议的召集和召开符合《公司 法》和《公司章程》等有关规定，会议合法、有效。会议由监事会主席吴艳女 士主持，与会监事以记名投票方式投票表决，经认真研究审议形成决议如下： 二、监事会会议审议情况 根据《公司法》《上海证券交易所科创板股票上市规则》及其他有关法律、 法规及规范性文件的规定，结合公司实际情况，经认真研究审议，监事会形成 决议如下： （一）审议通过了《关于<2024 年年度报告>全文及其摘要的议案》 公司 2024 年年 ...

证券代码：688115 证券简称：思林杰 公告编号：2025-022 重要内容提示： 每股分配比例：每股派发现金红利 0.22 元（含税），不进行资本公积金 转增股本，不送红股。 本次利润分配以实施权益分派股权登记日登记的广州思林杰科技股份有 限公司（以下简称"公司"）总股本为基数，具体日期将在权益分派实施公告中 明确。在实施权益分派的股权登记日前，公司总股本发生变动的，公司拟维持每 股分配比例不变，相应调整分配总额，并将另行公告具体调整情况。 为进一步加大投资者回报力度，公司董事会提请股东会授权董事会根据 股东会决议在符合利润分配的前提条件下制定和实施 2025 年中期分红方案。 公司未触及《上海证券交易所科创板股票上市规则》第 12.9.1 条第一款 第（八）项规定的可能被实施其他风险警示的情形。 一、利润分配预案内容 （一）利润分配方案具体内容 经天健会计师事务所（特殊普通合伙）审计，2024 年度合并报表中归属于 上市公司股东的净利润为 15,273,060.85 元。截至 2024 年 12 月 31 日，母公司累 计未分配利润为 119,345,807.26 元。经公司董事会审议，本次利润分配方案 ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.2300 | 0.1300 | 76.92 | 0.8600 | | 每股净资产（元） | 0 | 19.32 | -100 | 19.99 | | 每股公积金(元) | 16.07 | 16.41 | -2.07 | 16.33 | | 每股未分配利润(元) | 1.79 | 2.01 | -10.95 | 2.35 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.85 | 1.68 | 10.12 | 2.42 | | 净利润(亿元) | 0.15 | 0.09 | 66.67 | 0.54 | | 净资产收益率(%) | | 0.68 | -100 | 5.04 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 2226.32万股，累计占流通股比： 52.82%，较上期变化： 3 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥31,710,954.27, representing a 20.83% increase compared to ¥26,243,560.85 in the same period last year[3]. - The net profit attributable to shareholders was -¥12,541,274.58, a decrease of 546.94% from a profit of ¥2,806,035.56 in the previous year[3]. - Total operating revenue for Q1 2025 reached ¥31,710,954.27, a 20.5% increase from ¥26,243,560.85 in Q1 2024[15]. - Net profit for Q1 2025 was a loss of ¥12,541,274.58, compared to a profit of ¥2,806,035.56 in Q1 2024[16]. - The company reported a total comprehensive loss of ¥12,538,571.68 in Q1 2025, compared to a comprehensive income of ¥2,805,459.60 in Q1 2024[16]. Cash Flow and Assets - The net cash flow from operating activities was ¥7,385,690.84, a significant improvement from -¥10,799,735.21 in the same period last year[3]. - Cash flow from operating activities generated a net inflow of ¥7,385,690.84 in Q1 2025, contrasting with a net outflow of ¥10,799,735.21 in Q1 2024[18]. - Cash and cash equivalents decreased to CNY 625,007,416.36 from CNY 820,957,686.09, representing a decline of about 23.9%[11]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥622,438,926.36, down from ¥909,183,442.94 at the end of Q1 2024[19]. - The company's current assets totaled CNY 1,081,377,564.08, down from CNY 1,104,629,429.94 in the previous period, indicating a decrease of approximately 2.4%[11]. Expenses and Liabilities - Research and development expenses totaled ¥14,169,628.05, accounting for 44.68% of operating revenue, a slight decrease of 0.46 percentage points from 45.14%[3]. - Total operating costs increased to ¥46,308,457.10 in Q1 2025, up 30.4% from ¥35,537,854.94 in Q1 2024[15]. - Research and development expenses for Q1 2025 were ¥14,169,628.05, an increase of 19.5% from ¥11,845,032.38 in Q1 2024[15]. - The company's total liabilities decreased to CNY 114,226,860.12 from CNY 124,476,625.25, reflecting a reduction of approximately 8.1%[13]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,792[8]. - The top shareholder, Zhou Maolin, holds 15,727,700 shares, representing 23.59% of the total shares[8]. Asset Changes - The total assets at the end of the reporting period were ¥1,374,436,713.25, a decrease of 1.04% from ¥1,388,824,565.76 at the end of the previous year[3]. - As of March 31, 2025, the total assets of the company amounted to CNY 1,374,436,713.25, a slight decrease from CNY 1,388,824,565.76 at the end of 2024[11]. - The total equity attributable to shareholders was CNY 1,260,209,853.13, slightly down from CNY 1,264,347,940.51, indicating a decrease of about 0.3%[13]. - The company reported a total of CNY 190,000,000.00 in trading financial assets as of March 31, 2025, significantly up from CNY 30,250,000.00 previously, marking an increase of 528.9%[11]. - The inventory increased to CNY 61,896,001.15 from CNY 48,391,587.34, which is an increase of approximately 28.0%[12]. - The company’s accounts receivable slightly increased to CNY 192,446,224.45 from CNY 190,601,345.62, reflecting a growth of about 1.0%[11]. Other Information - The company reported non-recurring gains and losses totaling ¥530,520.34 for the period[5]. - The company has not reported any changes in the participation of major shareholders in financing or securities lending activities[10]. - There are no significant new strategies or product developments mentioned in the current report[10].

Financial Performance - The company's operating revenue for 2024 reached ¥185,316,037.93, representing a 10.14% increase compared to ¥168,250,840.04 in 2023[22]. - Net profit attributable to shareholders for 2024 was ¥15,273,060.85, a significant increase of 69.99% from ¥8,984,430.03 in 2023[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥8,801,381.74, up 234.99% from ¥2,627,367.16 in 2023[22]. - The main business revenue increased by 10.09% to ¥184,507,474.96, driven by an expansion in sales scale[134]. - The gross margin improved to 45%, up from 40% in the previous year, reflecting better cost management and pricing strategies[182]. - The company achieved operating revenue of ¥185,316,037.93 in 2024, representing a year-on-year growth of 10.14%[129]. - The main business cost rose by 21.46% to ¥79,678,446.66, leading to a decrease in gross margin by 4.04 percentage points to 56.82%[134]. Research and Development - The company reported a significant increase in R&D efforts, focusing on new technologies and products to drive future growth[22]. - R&D expenses as a percentage of revenue for 2022, 2023, and 2024 are 25.43%, 30.95%, and 26.57% respectively, highlighting the company's commitment to innovation[34]. - The total R&D investment for the year was CNY 49.24 million, a decrease of 5.45% compared to the previous year[106]. - The company has developed 13 core technologies related to industrial automation and machine vision detection, maintaining their advanced status during the reporting period[96]. - The company has invested 100 million yuan in R&D for new technologies, aiming to innovate its product line and improve service offerings[182]. - The company is committed to enhancing its research and development capabilities and expand its product matrix to include sectors such as semiconductors, biomedical, and new energy[164]. Corporate Governance - The company has received a standard unqualified audit report from Tianjian Accounting Firm[4]. - The company has not disclosed any special arrangements for corporate governance[5]. - The company has established specialized committees within the board, including an Audit Committee and a Strategic Committee, to enhance governance[197]. - The board held a total of 12 meetings this year, with 8 conducted in a hybrid format combining in-person and remote participation[195]. - The company has implemented a comprehensive internal control system to ensure compliance, asset security, and the integrity of financial reporting, promoting sustainable development[174]. - The company has appointed new independent directors, enhancing its governance structure[181]. Market Strategy and Expansion - The company aims to improve its market position through strategic mergers and acquisitions, as evidenced by the recent acquisition activity[13]. - The company plans to deepen its focus on the consumer electronics sector while diversifying its business into various downstream application industries[164]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[182]. - Market expansion plans include entering two new international markets by Q3 2024, projected to increase market share by 5%[184]. - The company is considering strategic acquisitions to bolster its technology portfolio, with a budget of 300 million RMB allocated for potential deals[186]. Risk Management - The company has detailed various risk factors in its management discussion and analysis section, which investors should be aware of[3]. - The company faces risks related to intensified competition in the modular testing instrument sector, necessitating timely updates to technology and product innovation[127]. - The company has confirmed that all directors attended the board meeting[4]. - The company has not violated any decision-making procedures regarding external guarantees[7]. - The company has established stable business relationships with major consumer electronics companies, enhancing product quality and efficiency[117]. Employee and Compensation - The company has implemented an employee stock ownership plan to align the interests of shareholders, the company, and employees, enhancing team cohesion and competitiveness[38]. - Total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to 521.39 million yuan[188]. - Total remuneration for core technical personnel at the end of the reporting period was 383.83 million yuan[188]. - The number of R&D personnel increased to 181, accounting for 60.74% of the total workforce, up from 53.19% in the previous period[113]. - The average salary for R&D personnel decreased slightly to 25.83 million from 26.20 million[113]. Product Development and Innovation - The company has developed its own modular instrument platform named NYSA, enhancing its product offerings[13]. - The company focuses on precision measurement, high-speed signal measurement, and RF testing in its new product development, aiming to meet diverse customer needs[36]. - The modular instruments developed by the company integrate advanced software and measurement technologies, enhancing user configuration and maintenance capabilities while reducing hardware replacement costs[76]. - The company has developed a digital audio interface technology that utilizes FPGA to implement various digital audio interfaces, enhancing signal collection capabilities[99]. - The company is committed to enhancing its product offerings through continuous innovation in embedded systems and automation technologies[100]. Financial Strategy - The company plans to use part of its temporarily idle funds for cash management as approved in the board meeting on March 27, 2024[192]. - The company plans to raise matching funds, with details on the amount and intended use of these funds outlined in the proposal[193]. - The company has submitted a rectification report following the regulatory measures taken by the CSRC[190]. - The company is in the process of revising its governance documents, including the Articles of Association and various committee work rules[192]. - The company approved a proposal for issuing shares and cash to acquire assets and raise matching funds, indicating a strategic move for growth[193].

| | | | 一、审计报告……………………………………………………… 第 1—5 页 | | --- | | 二、财务报表……………………………………………………… 第 6—13 页 | | （一）合并资产负债表…………………………………………… 第 6 页 | | （二）母公司资产负债表………………………………………… 第 7 页 | | （三）合并利润表………………………………………………… 第 8 页 | | （四）母公司利润表……………………………………………… 第 9 页 | | （五）合并现金流量表……………………………………………第 10 页 | | （六）母公司现金流量表…………………………………………第 11 页 | | （七）合并所有者权益变动表……………………………………第 12 页 | | （八）母公司所有者权益变动表…………………………………第 13 页 | | | | | | | 审 计 报 告 天健审〔2025〕7-528 号 广州思林杰科技股份有限公司全体股东： 一、审计意见 我们审计了广州思林杰科技股份有限公司（以下简称思林杰公司）财务报表， 包括 2024 年 12 月 ...

2024 年度募集资金存放和实际使用情况的核查意见 民生证券股份有限公司（以下简称"保荐机构"）作为广州思林杰科技股份有 限公司（以下简称"思林杰"或"公司"）首次公开发行股份并在科创板上市的保荐 机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上 市规则》等有关规定等有关法律法规和规范性文件的要求，保荐机构对思林杰 2024 年度募集资金存放与实际使用情况的事项进行了专项核查，并发表如下意 见： 一、持续督导工作情况 中国证券监督管理委员会于 2022 年 1 月 18 日核发《关于同意广州思林杰科 技股份有限公司首次公开发行股票注册的批复》证监许可〔2022〕130 号。公司 于 2022 年 3 月 14 日在上海证券交易所首次公开发行人民币普通股（A 股）1,667 万股并上市。本次发行募集资金总额 109,438.55 万元，全部为公司公开发行新股 募集，扣除发行费用（不含增值税）人民币 11,889.44 万元后，募集资金净额为 97,549.11 万元。募集资金已由民生证券股份有限公司于 2022 年 3 月 9 日汇入公 司募集资金监管户。天健会计师事务所（特殊普通合伙）对 ...

目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告…………… 第 3—12 页 三、资格证书复印件………………………………………………第 13—16 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕7-530 号 广州思林杰科技股份有限公司全体股东： 我们鉴证了后附的广州思林杰科技股份有限公司（以下简称思林杰公司）管 理层编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供思林杰公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为思林杰公司年度报告的必备文件，随同其他文件一起 报送并对外披露。 二、管理层的责任 思林杰公司管理层的责任是提供真实、合法、完整的相关资料，按照《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修 订）》（证监会公告〔2022〕15 号）和《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作（2023 年 12 月修订）》（上证发〔2023〕194 号） 的规定编制《关 ...